Therefore, the aim of this study was to determine whether four variants in the <i>OAS1</i> and <i>OAS3</i> genes are associated with susceptibility to COVID-19 and with the clinical signs and symptoms of the disease. This evidence concerns the gene OAS3 and COVID-19.